Document is current
Any future updates will be listed below
-
Authors
Emilsson, Valur http://orcid.org/0000-0001-9982-0524
Gudmundsson, Elias F. http://orcid.org/0000-0002-7661-4872
Jonmundsson, Thorarinn http://orcid.org/0000-0001-9158-0087
Jonsson, Brynjolfur G.
Twarog, Michael
Gudmundsdottir, Valborg
Li, Zhiguang
Finkel, Nancy
Poor, Stephen http://orcid.org/0000-0003-4374-1178
Liu, Xin
Esterberg, Robert
Zhang, Yiyun
Jose, Sandra
Huang, Chia-Ling
Liao, Sha-Mei
Loureiro, Joseph
Zhang, Qin
Grosskreutz, Cynthia L.
Nguyen, Andrew A.
Huang, Qian
Leehy, Barrett
Pitts, Rebecca http://orcid.org/0000-0003-4733-414X
Aspelund, Thor http://orcid.org/0000-0002-7998-5433
Lamb, John R.
Jonasson, Fridbert
Launer, Lenore J. http://orcid.org/0000-0002-3238-7612
Cotch, Mary Frances http://orcid.org/0000-0002-2046-4350
Jennings, Lori L. http://orcid.org/0000-0001-5130-8417
Gudnason, Vilmundur http://orcid.org/0000-0001-5696-0084
Walshe, Tony E. http://orcid.org/0000-0001-7055-8251
-
Funding
Funding for this research was provided by:
The Icelandic Research Fund - RANNIS
- License Information
-
More Information
Article History
Received: 6 August 2021
Accepted: 1 June 2022
First Online: 13 June 2022
Competing interests
: The study was supported by the Novartis Institute for Biomedical Research. M.T., N.F., S.P., X.L., R.E., Y.Z., S.J., C.L.H., S.M.L., J.L., C.L.G., A.A.N., B.L., R.P., Z.L., L.L.J., T.E.W., Q.Z., Q.H., and J.R.L. are employees and stockholders of Novartis. All other authors have no conflict of interests to declare.
